Conclusions: Immunohistochemistry can make significant contributions to the diagnosis of sebaceouscarcinoma.
2
Purpose: To evaluate the fine cytopathologic features and immunohistochemistry of eyelid sebaceouscarcinoma.
3
This report supports prospective clinical trials of anti-PD1 checkpoint blockade for metastatic sebaceouscarcinoma.
4
Methods: Clinical records and microscopic glass slides of 12 patients diagnosed with sebaceouscarcinoma were reviewed.
5
Histologically, the tumor was diagnosed as sebaceouscarcinoma.
6
Physicians should be mindful that sebaceouscarcinoma in kidney transplant recipients is highly concurrent with Muir-Torre syndrome.
7
Conclusions: This is the first report describing objective clinical and radiographic responses following immunotherapy for widely metastatic sebaceouscarcinoma.
8
In the final excision specimen, both the dura mater and the brain tissue were infiltrated by the sebaceouscarcinoma.
9
We report the case of a female kidney transplant recipient with sebaceouscarcinoma concurrent with colon cancer 10 years after transplantation.
10
Sebaceouscarcinoma is sometimes found concurrently with visceral cancers and a genetic abnormality, Muir-Torre syndrome.
11
Sebaceouscarcinoma is a rare, aggressive, malignant tumor derived from the adnexal epithelium of sebaceous glands.
12
BACKGROUND: Sebaceouscarcinoma is a rare malignancy primarily with aggressive growth affecting the cutaneous tissues of the periocular region.
13
Background: Sebaceouscarcinoma is an aggressive adnexal skin tumor with a predilection for the eyelids and sebaceous glands of the head and neck.
14
Herein we report the case of a 62-year-old man with mismatch repair deficient metastatic colorectal adenocarcinoma, urothelial carcinoma and a history of sebaceouscarcinomas.